Explore the vast range of titles available.

Pursuing Gender Equity in Primary CareGender-based pay disparities underscore the need to design a payment system that adequately compensates physicians for the thoughtful, relationship-based care that defines excellent primary care.

This study brings trans women to the forefront of global discourse on gender‐based economic inequalities. Such discussions, often lacking intersectionality and narrowly focused on cis women, have frequently overlooked the distinct economic obstacles trans women face in cisheteropatriarchal societies. Grounded in critical trans politics and intersectionality, this research explores the lives of five trans women in South Africa, examining the contextual norms, practices, and policies that shape their experiences of economic inclusion and exclusion. Findings reveal that economic marginality for trans women is upheld by social institutions prioritizing cisgender norms, reinforcing biology‐based gender binaries that render those existing outside these frameworks vulnerable, disposable, and disenfranchised. This structural economic bias is reflected in four key areas: (a) patriarchal family systems enforce conformity to cisgender expectations through abuse, financial neglect, and rejection, displacing trans women into precarious circumstances, including homelessness and survival sex work; (b) cisnormative workplace conventions demand legal gender alignment as a precondition for organizational access and employability, shutting out trans identities lacking state recognition of their gender; (c) institutionally entrenched anti‐trans stigma creates heightened scrutiny and discrimination during hiring processes; and (d) a gender‐segregated labor system undermines trans women’s ability to participate in both “male” and “female” jobs due to nonadherence to traditional, biologically defined gender roles. These cisgender‐privileging norms intersect with racism and colonial‐apartheid legacies, compounding economic difficulties for trans women. By mapping the economic conditions of historically invisibilized trans women, this study deepens the scope of economic transformation theories. It calls for a trans‐inclusive, intersectional model of economic justice, advocating for institutional cultures that embrace diverse gender expressions beyond static gender classifications.

The role of the National Health Service (NHS) and relevant national executive agencies in relation to testing capacity, availability of personal protective equipment (PPE), the cancellation and postponement of many aspects of routine care, and decisions around discharge from hospital to care homes should also be critically examined. [...]improve resource management across health and care at national, local, and treatment levels. [...]develop a sustainable, skilled, and fit for purpose health and care workforce to meet changing health and care needs. [...]improve integration between health care, social care, and public health and across different providers, including the third sector (ie, charity and voluntary organisations).

COVID-19 has affected vulnerable populations disproportionately across China and the world. Solid social and scientific evidence to tackle health inequity in the current COVID-19 pandemic is in urgent need.

Between 1991 and 2015, the cancer mortality rate declined dramatically in the United States, reflecting improvements in cancer prevention, screening, treatment, and survivorship care. However, cancer outcomes in the United States vary substantially between populations defined by race/ethnicity, socioeconomic status, health insurance coverage, and geographic area of residence. Many potentially preventable cancer deaths occur in individuals who did not receive effective cancer prevention, screening, treatment, or survivorship care. At the same time, cancer care spending is large and growing, straining national, state, health insurance plans, and family budgets. Indeed, one of the most pressing issues in American medicine is how to ensure that all populations, in every community, derive the benefit from scientific research that has already been completed. Addressing these questions from the perspective of health care delivery is necessary to accelerate the decline in cancer mortality that began in the early 1990s. This article, part of the Cancer Control Blueprint series, describes challenges with the provision of care across the cancer control continuum in the United States. It also identifies goals for a high‐performing health system that could reduce disparities and the burden of cancer by promoting the adoption of healthy lifestyles; access to a regular source of primary care; timely access to evidence‐based care; patient‐centeredness, including effective patient‐provider communication; enhanced coordination and communication between providers, including primary care and specialty care providers; and affordability for patients, payers, and society.

Increasing attention is being paid to the inequity that pervades global health research. One behind-the-scenes component of the research enterprise that hasn’t been addressed is the indirect cost rate.

Considering the consumer’s anticipated regret caused by price discount, the impact of anticipated regret and manufacturers’ fairness concerns on pricing and profits is explored, and a revenue-sharing contract to optimize the profits of supply chain is explored. In centralized decision-making model with manufacturer’s fairness neutrality and retailer-led decentralized decision-making model with the manufacturer’s fairness concerns, numerical simulation and model comparison is used to analyse regret sensitivity coefficient, consumer heterogeneity, the fairness concern coefficient on pricing decisions and profit coordination. Our results reveal that consumer’s anticipated regret has a negative impact on product prices, retailer’s profit and manufacturer’s profit. Manufacturer’s fairness concerns also increase product price and reduce profits of all parties. Retailer-led supply chain can share the revenue to achieve Pareto optimization. When formulating promotional strategies, retailers should consider the characteristics of anticipated regrets of consumers.